PCSK1 and chronic myelogenous leukemia, BCR-ABL1 positive: The fluorescence images in Figure 3A indicate that shikonin treatment led to intracellular ROS accumulation in CML cells, which was markedly inhibited in the presence of Nec-1 but not zVAD-fmk.